| SL 0101-1 |
ENSG00000088970.11 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000118412.8 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SL 0101-1 |
ENSG00000118412.8 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000157152.12 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000157306.10 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000163364.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000164621.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000167355.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000170161.6 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000172250.10 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000172965.10 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000173867.8 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000174171.4 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000175701.6 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000175967.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000177337.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000178977.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000179859.7 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000180422.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000182376.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SL 0101-1 |
ENSG00000184068.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000186019.10 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000186615.6 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000187156.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SL 0101-1 |
ENSG00000189419.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000196421.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000196559.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000196951.6 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000196972.6 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000197210.7 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000197813.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000197934.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000198106.7 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000203279.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000203288.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000203288.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000203434.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000203588.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000203601.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000203650.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000203865.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000204272.6 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000204792.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000204792.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000204802.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000204802.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000205054.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000205266.5 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000205500.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000205500.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000205628.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000205885.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000206140.5 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000206195.6 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000212163.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000212552.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000212552.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000212766.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000212939.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000213279.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000213863.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000214145.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000214145.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000214293.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000214401.4 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000214733.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000215022.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000215039.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000215241.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000215394.4 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000223374.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000223380.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000223390.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000223390.1 |
Predicted lncRNA |
Sarcoma |
|
| SL 0101-1 |
ENSG00000223396.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000223396.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000223478.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000223482.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000223486.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000223525.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SL 0101-1 |
ENSG00000223653.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000223692.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000223697.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000223774.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000223791.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000223791.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000223799.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000223842.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000223901.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000223935.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000224029.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000224031.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000224086.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000224093.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000224138.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000224184.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000224356.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000224376.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000224505.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000224533.3 |
Predicted lncRNA |
Sarcoma |
|
| SL 0101-1 |
ENSG00000224577.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000224592.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000224596.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000224596.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000224597.5 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000224635.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000224746.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000224761.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000224764.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000224799.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000224804.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000224818.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000224818.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000224822.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000224843.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000224846.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000224888.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000224934.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000224939.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000224950.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000224950.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000224959.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000224972.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000224975.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000224977.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000224985.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000225037.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000225076.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000225083.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000225084.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000225096.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000225113.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000225140.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000225156.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000225163.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000225195.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000225210.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000225213.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000225235.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000225269.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000225302.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000225328.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000225331.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000225377.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000225411.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000225434.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000225439.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000225442.2 |
Predicted lncRNA |
Sarcoma |
|
| SL 0101-1 |
ENSG00000225489.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000225675.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SL 0101-1 |
ENSG00000225721.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000225725.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000225744.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000225751.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000225751.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000225767.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000225913.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000226067.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000226101.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000226155.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000226245.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000226330.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000226380.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000226471.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000226520.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000226599.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000226637.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000226649.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000226649.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000226699.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000226797.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000226833.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000226833.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000226852.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000226862.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000226876.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000226944.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000227006.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000227071.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000227082.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000227197.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000227200.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000227210.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000227218.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000227245.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000227245.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000227245.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000227359.1 |
Predicted lncRNA |
Sarcoma |
|
| SL 0101-1 |
ENSG00000227359.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000227374.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000227431.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000227456.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000227479.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000227527.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000227543.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000227574.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000227589.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000227598.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000227617.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000227740.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000227773.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000227848.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000227848.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000227857.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000227914.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000227946.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000228028.2 |
Predicted lncRNA |
Sarcoma |
|
| SL 0101-1 |
ENSG00000228065.6 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000228065.6 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000228072.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SL 0101-1 |
ENSG00000228113.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000228115.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000228135.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000228201.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000228203.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000228237.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000228261.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000228293.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000228294.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000228302.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000228323.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000228386.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000228393.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000228395.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000228395.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000228404.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000228412.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000228412.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000228463.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000228463.4 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000228506.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000228506.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000228527.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000228549.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000228604.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000228639.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000228701.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000228802.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000228809.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000228809.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000228839.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000228865.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000228878.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000228889.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000228956.4 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000228956.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000229081.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000229109.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SL 0101-1 |
ENSG00000229109.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000229109.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000229127.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000229152.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000229153.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000229155.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000229167.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000229178.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000229190.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000229311.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000229325.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000229525.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000229582.2 |
Predicted lncRNA |
Sarcoma |
|
| SL 0101-1 |
ENSG00000229587.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000229587.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000229591.1 |
Predicted lncRNA |
Sarcoma |
|
| SL 0101-1 |
ENSG00000229694.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000229697.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000229719.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000229728.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000229841.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000229869.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000229873.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000229931.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000229951.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000229952.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000229953.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000229983.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000229989.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000230058.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000230061.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000230074.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000230082.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000230177.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000230177.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000230337.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000230499.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000230530.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000230563.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000230587.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000230615.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000230615.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000230699.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000230699.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000230724.5 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000230725.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000230806.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000230825.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000230912.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000230912.1 |
Predicted lncRNA |
Sarcoma |
|
| SL 0101-1 |
ENSG00000230918.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000230939.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000231064.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000231104.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000231113.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000231119.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000231154.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000231193.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000231252.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000231367.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000231393.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000231393.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000231527.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000231527.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000231530.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000231530.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000231566.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000231616.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000231616.4 |
Predicted lncRNA |
Sarcoma |
|
| SL 0101-1 |
ENSG00000231636.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000231636.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000231663.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000231691.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000231704.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000231709.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000231711.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000231728.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000231734.4 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000231789.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000231856.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000231856.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000231856.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000231871.1 |
Predicted lncRNA |
Sarcoma |
|
| SL 0101-1 |
ENSG00000231871.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000231889.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000231992.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000231999.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000232034.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000232043.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000232093.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000232116.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000232118.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000232184.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000232194.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000232224.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000232229.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000232274.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000232300.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000232352.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000232411.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000232412.1 |
Predicted lncRNA |
Sarcoma |
|
| SL 0101-1 |
ENSG00000232442.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000232453.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000232470.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000232490.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000232536.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000232611.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000232613.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000232640.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000232648.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SL 0101-1 |
ENSG00000232656.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000232692.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000232696.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000232698.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000232710.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000232712.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000232739.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000232756.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000232762.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000232807.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000232827.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SL 0101-1 |
ENSG00000232907.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000232913.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000232913.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000232936.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SL 0101-1 |
ENSG00000232936.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000232978.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000233008.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000233013.4 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000233030.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000233033.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000233033.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000233060.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SL 0101-1 |
ENSG00000233060.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000233086.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000233101.6 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000233117.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000233191.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000233396.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000233427.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000233547.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000233611.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000233613.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000233621.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000233627.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000233654.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SL 0101-1 |
ENSG00000233654.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000233672.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000233695.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000233725.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000233818.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000233825.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000233844.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SL 0101-1 |
ENSG00000233850.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000233893.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000233967.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000233975.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000234006.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000234136.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000234199.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000234225.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000234225.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000234252.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000234263.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000234311.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000234405.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000234432.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000234449.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000234459.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000234459.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000234492.4 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000234571.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000234584.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000234650.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000234678.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000234689.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000234695.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000234695.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000234698.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000234703.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000234705.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000234740.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000234753.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000234771.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000234779.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000234793.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000234793.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000234899.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000234912.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000234943.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000234945.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000235027.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000235078.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000235106.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000235209.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000235214.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000235262.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000235293.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000235303.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000235314.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000235387.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000235398.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000235407.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000235481.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000235481.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000235530.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000235560.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000235586.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000235641.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000235702.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000235706.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000235706.3 |
Predicted lncRNA |
Sarcoma |
|
| SL 0101-1 |
ENSG00000235802.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000235813.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000235831.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000235939.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000235954.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000235954.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000235979.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000236003.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000236031.1 |
Predicted lncRNA |
Sarcoma |
|
| SL 0101-1 |
ENSG00000236144.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000236194.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000236194.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000236199.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000236200.1 |
Predicted lncRNA |
Sarcoma |
|
| SL 0101-1 |
ENSG00000236206.1 |
Predicted lncRNA |
Sarcoma |
|
| SL 0101-1 |
ENSG00000236209.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000236255.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000236333.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000236345.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000236377.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000236423.1 |
Predicted lncRNA |
Sarcoma |
|
| SL 0101-1 |
ENSG00000236438.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000236438.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000236472.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SL 0101-1 |
ENSG00000236498.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000236499.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000236514.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000236558.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000236641.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000236703.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000236833.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000236861.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000236869.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000236896.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000236908.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000236908.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000236908.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000236914.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000236935.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000236953.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000236986.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000237074.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000237125.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000237152.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000237200.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000237222.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000237253.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000237280.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000237402.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000237423.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000237424.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000237436.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000237476.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000237485.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000237485.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000237520.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000237587.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000237605.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000237614.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000237686.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000237768.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000237786.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000237805.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000237852.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000237886.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000237903.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000237940.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000237945.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000237945.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000237950.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000237975.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000237976.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000237978.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000238005.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000238009.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000238018.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000238018.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000238043.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000238113.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000238120.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000238140.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000238142.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000238210.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000238224.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000238273.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000238290.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000239002.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000239002.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000239213.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000239552.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000239653.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000239906.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000239911.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000239945.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000240015.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000240040.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000240211.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000240291.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000240350.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000240373.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000240373.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000240453.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000240541.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000240571.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000240661.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000240766.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000240990.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000241014.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000241014.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000241180.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000241211.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000241211.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000241219.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000241288.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000241409.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000241472.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000241544.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000241570.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000241720.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000241769.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000241770.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000241954.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000242094.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000242104.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000242553.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000242553.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000242553.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000242759.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000242861.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000242861.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000243018.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000243224.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000243224.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000243276.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000243433.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SL 0101-1 |
ENSG00000243766.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000243960.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000244124.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000244198.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000244265.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000244265.1 |
Predicted lncRNA |
Sarcoma |
|
| SL 0101-1 |
ENSG00000244306.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000244380.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000244479.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000244586.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000244738.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000244791.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000244945.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000244968.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000245080.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000245112.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SL 0101-1 |
ENSG00000245112.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000245148.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000245164.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000245275.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000245479.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000245522.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000245694.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000245729.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000245812.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000245904.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000246089.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000246174.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000246250.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000246263.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000246422.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000246740.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000246777.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000246790.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000246792.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000246898.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000246982.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000247151.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SL 0101-1 |
ENSG00000247199.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000247373.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000247400.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000247400.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000247498.5 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000247809.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000247853.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000248008.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000248008.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000248019.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000248243.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000248254.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000248256.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000248256.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000248388.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000248468.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000248508.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000248538.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000248559.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000248559.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000248576.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000248664.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000248671.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000248671.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000248671.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000248844.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000248846.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000248890.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000248896.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000248925.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000248936.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000248936.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000248968.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000249035.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000249084.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000249096.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000249096.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000249279.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000249304.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000249378.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000249417.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000249464.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000249593.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000249641.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000249781.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000249806.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000249825.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000249825.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000249859.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000249870.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000249898.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000249898.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000249916.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000250012.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000250033.1 |
Predicted lncRNA |
Sarcoma |
|
| SL 0101-1 |
ENSG00000250075.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SL 0101-1 |
ENSG00000250081.1 |
Predicted lncRNA |
Sarcoma |
|
| SL 0101-1 |
ENSG00000250103.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000250116.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000250122.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000250155.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000250156.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000250302.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000250303.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000250312.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000250511.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000250582.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000250592.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000250602.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000250608.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000250614.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000250659.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000250714.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000250740.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000250764.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000250889.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000250903.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000250903.4 |
Predicted lncRNA |
Sarcoma |
|
| SL 0101-1 |
ENSG00000250903.4 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000250910.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000250999.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000251009.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000251011.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000251018.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000251023.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000251026.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000251031.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000251034.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000251072.2 |
Predicted lncRNA |
Sarcoma |
|
| SL 0101-1 |
ENSG00000251141.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000251151.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000251169.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000251175.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000251191.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000251221.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000251359.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000251361.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000251363.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000251365.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000251497.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000251497.2 |
Predicted lncRNA |
Sarcoma |
|
| SL 0101-1 |
ENSG00000251555.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000251574.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000251576.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000251603.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000251867.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SL 0101-1 |
ENSG00000253106.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000253121.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000253171.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000253190.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000253284.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000253307.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000253476.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000253500.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000253508.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000253513.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000253618.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000253632.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000253636.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000253736.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000253738.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000253741.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000253754.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000253766.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000253799.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000253819.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000253824.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000253829.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000253854.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000253878.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000253893.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000253955.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000254003.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000254034.1 |
Predicted lncRNA |
Sarcoma |
|
| SL 0101-1 |
ENSG00000254094.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000254099.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000254197.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000254207.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000254208.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000254295.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000254333.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000254396.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000254409.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000254431.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000254433.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000254459.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000254480.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000254485.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000254539.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000254560.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000254592.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000254605.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000254607.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000254615.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000254638.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000254675.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000254694.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000254703.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000254731.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000254791.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000254842.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000254846.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000254862.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000254869.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000254966.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000254973.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000254990.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000255002.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000255026.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000255084.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000255094.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000255164.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000255274.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000255318.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000255325.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000255334.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000255446.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000255449.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000255509.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000255516.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000255517.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000255520.1 |
Predicted lncRNA |
Sarcoma |
|
| SL 0101-1 |
ENSG00000255521.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000255539.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000255557.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SL 0101-1 |
ENSG00000255559.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000255794.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000255867.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000255970.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000255980.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000255989.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000256050.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000256084.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000256124.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000256155.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000256248.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000256417.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000256588.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000256596.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000256705.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000256712.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000256739.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SL 0101-1 |
ENSG00000256742.1 |
Predicted lncRNA |
Sarcoma |
|
| SL 0101-1 |
ENSG00000256789.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000256789.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000256894.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000256940.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SL 0101-1 |
ENSG00000256940.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000257004.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000257004.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000257027.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000257086.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000257086.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000257167.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000257193.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000257261.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000257285.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000257410.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000257449.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000257449.1 |
Predicted lncRNA |
Sarcoma |
|
| SL 0101-1 |
ENSG00000257475.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000257488.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000257496.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000257507.1 |
Predicted lncRNA |
Sarcoma |
|
| SL 0101-1 |
ENSG00000257509.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000257515.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000257534.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000257551.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000257556.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000257568.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000257568.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000257613.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000257647.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000257647.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000257696.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000257696.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000257702.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000257718.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000257740.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000257815.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000257894.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000257894.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000257900.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000258017.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SL 0101-1 |
ENSG00000258077.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000258099.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000258137.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000258168.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000258199.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000258260.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000258274.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000258303.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000258325.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000258343.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000258355.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000258378.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000258413.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000258413.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000258428.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000258450.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000258537.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000258545.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000258561.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SL 0101-1 |
ENSG00000258593.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000258682.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000258725.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000258766.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000258777.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000258808.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000258809.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000258811.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000258825.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000258858.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000258904.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000258922.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000258982.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000259002.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000259038.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000259083.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000259083.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000259118.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000259146.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000259158.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000259182.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000259198.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000259201.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000259238.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000259240.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000259244.1 |
Predicted lncRNA |
Sarcoma |
|
| SL 0101-1 |
ENSG00000259248.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000259254.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000259274.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SL 0101-1 |
ENSG00000259287.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000259287.1 |
Predicted lncRNA |
Sarcoma |
|
| SL 0101-1 |
ENSG00000259294.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000259298.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000259306.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000259345.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000259353.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000259380.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000259407.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000259408.1 |
Predicted lncRNA |
Sarcoma |
|
| SL 0101-1 |
ENSG00000259416.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000259417.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000259422.1 |
Predicted lncRNA |
Sarcoma |
|
| SL 0101-1 |
ENSG00000259436.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000259439.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000259445.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000259453.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000259504.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000259515.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000259520.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000259520.1 |
Predicted lncRNA |
Sarcoma |
|
| SL 0101-1 |
ENSG00000259521.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000259540.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000259548.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000259553.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000259590.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000259617.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000259618.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000259652.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000259654.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000259668.1 |
Predicted lncRNA |
Sarcoma |
|
| SL 0101-1 |
ENSG00000259678.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000259694.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000259713.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000259713.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000259715.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000259723.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000259735.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000259760.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000259762.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000259771.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000259771.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000259775.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000259782.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SL 0101-1 |
ENSG00000259783.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000259783.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000259797.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000259799.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000259806.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000259810.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000259818.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000259820.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000259876.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000259894.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000259921.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000259925.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000259933.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000260025.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000260037.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000260060.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000260077.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000260084.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000260118.1 |
Predicted lncRNA |
Sarcoma |
|
| SL 0101-1 |
ENSG00000260132.1 |
Predicted lncRNA |
Sarcoma |
|
| SL 0101-1 |
ENSG00000260136.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000260136.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000260167.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000260176.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000260176.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000260177.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000260188.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SL 0101-1 |
ENSG00000260190.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000260193.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000260194.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000260231.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000260233.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000260269.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000260285.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000260285.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000260329.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000260351.1 |
Predicted lncRNA |
Sarcoma |
|
| SL 0101-1 |
ENSG00000260360.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000260367.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000260368.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000260369.2 |
Predicted lncRNA |
Sarcoma |
|
| SL 0101-1 |
ENSG00000260388.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000260409.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000260423.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000260436.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000260464.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000260464.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000260468.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000260495.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000260515.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000260517.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000260523.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000260534.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000260545.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000260555.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000260572.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000260593.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000260597.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000260608.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000260616.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000260630.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000260645.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000260645.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000260647.1 |
Predicted lncRNA |
Sarcoma |
|
| SL 0101-1 |
ENSG00000260657.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000260661.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000260671.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000260671.1 |
Predicted lncRNA |
Sarcoma |
|
| SL 0101-1 |
ENSG00000260766.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000260777.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000260778.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000260792.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000260796.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000260803.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000260831.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000260841.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000260891.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000260907.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000260927.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000260936.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000260938.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000260941.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000260949.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000260955.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000260973.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000261040.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SL 0101-1 |
ENSG00000261043.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000261051.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000261080.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000261083.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000261101.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000261121.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000261123.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000261135.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000261140.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000261140.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000261168.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000261170.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000261173.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000261220.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SL 0101-1 |
ENSG00000261267.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000261280.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SL 0101-1 |
ENSG00000261280.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000261288.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000261288.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000261291.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000261329.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SL 0101-1 |
ENSG00000261329.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000261334.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000261334.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000261334.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000261357.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000261357.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000261369.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000261369.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000261369.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000261386.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000261396.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000261399.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000261399.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000261407.1 |
Predicted lncRNA |
Sarcoma |
|
| SL 0101-1 |
ENSG00000261428.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000261430.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000261431.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000261431.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000261451.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000261455.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000261474.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000261490.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000261512.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000261513.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000261544.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000261574.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000261574.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000261578.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000261584.1 |
Predicted lncRNA |
Sarcoma |
|
| SL 0101-1 |
ENSG00000261589.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000261596.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000261596.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000261597.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000261613.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000261662.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000261685.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000261685.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000261730.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000261786.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000261798.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000261799.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000261799.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000261801.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000261824.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000261840.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000261864.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000261879.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000262001.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000262115.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000262115.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000262136.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000262152.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000262171.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000262228.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000262362.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000262514.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000262580.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000262585.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000262662.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SL 0101-1 |
ENSG00000262663.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000262686.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000262833.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SL 0101-1 |
ENSG00000262848.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000262881.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000262905.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000262973.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000262979.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000262979.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SL 0101-1 |
ENSG00000263120.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000263154.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000263164.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000263214.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SL 0101-1 |
ENSG00000263293.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000263300.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000263316.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000263345.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000263443.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000263531.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000263627.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000263627.1 |
Predicted lncRNA |
Sarcoma |
|
| SL 0101-1 |
ENSG00000263657.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000263766.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000263766.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000263766.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000263847.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000263859.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000263860.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000263884.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000263916.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000263924.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000264007.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000264012.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000264083.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000264207.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000264269.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000264269.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000264270.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000264290.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000264304.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000264365.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000264569.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000264575.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000264808.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000264812.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000264860.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000264895.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000265094.1 |
Predicted lncRNA |
Sarcoma |
|
| SL 0101-1 |
ENSG00000265142.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000265142.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000265242.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000265349.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000265394.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000265443.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SL 0101-1 |
ENSG00000265474.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000265487.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000265490.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000265496.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000265519.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000265519.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000265666.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000265688.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000265743.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000265778.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000265778.1 |
Predicted lncRNA |
Sarcoma |
|
| SL 0101-1 |
ENSG00000265778.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000265787.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000265943.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000265992.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000266010.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000266040.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000266053.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000266111.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SL 0101-1 |
ENSG00000266120.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000266126.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000266283.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000266289.1 |
Predicted lncRNA |
Sarcoma |
|
| SL 0101-1 |
ENSG00000266368.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SL 0101-1 |
ENSG00000266541.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000266604.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000266717.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000266718.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000266801.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SL 0101-1 |
ENSG00000266803.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000266805.1 |
Predicted lncRNA |
Sarcoma |
|
| SL 0101-1 |
ENSG00000266918.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000266921.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000266924.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000266933.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000266934.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SL 0101-1 |
ENSG00000266941.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000266965.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000266976.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000267003.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000267026.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000267026.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000267044.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000267058.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SL 0101-1 |
ENSG00000267096.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000267112.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000267117.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000267130.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000267152.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000267169.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000267169.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000267191.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000267193.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000267222.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000267244.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000267263.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000267274.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SL 0101-1 |
ENSG00000267274.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000267278.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000267278.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000267287.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000267296.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000267299.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000267316.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000267325.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000267344.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000267348.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000267348.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000267390.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000267397.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000267405.1 |
Predicted lncRNA |
Sarcoma |
|
| SL 0101-1 |
ENSG00000267454.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000267476.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000267501.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000267505.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000267546.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000267546.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000267614.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000267666.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000267672.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000267702.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000267715.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000267743.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000267745.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000267747.1 |
Predicted lncRNA |
Sarcoma |
|
| SL 0101-1 |
ENSG00000267751.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000267778.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000267780.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000267786.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000267798.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000267798.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000267804.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000267804.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000267898.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000267905.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SL 0101-1 |
ENSG00000267934.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000267939.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000268006.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000268027.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000268049.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000268061.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000268157.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000268230.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000268257.2 |
Predicted lncRNA |
Sarcoma |
|
| SL 0101-1 |
ENSG00000268362.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000268364.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000268401.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000268458.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000268499.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000268516.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000268530.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000268544.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000268583.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000268583.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000268621.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SL 0101-1 |
ENSG00000268670.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000268683.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000268812.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000268812.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000268895.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000268931.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000268947.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000269054.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000269082.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000269082.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SL 0101-1 |
ENSG00000269107.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000269107.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000269194.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000269290.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000269321.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000269352.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000269365.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000269392.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000269423.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000269423.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000269427.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000269444.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000269473.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000269487.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000269487.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000269489.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000269534.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000269534.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000269535.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000269560.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000269560.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000269646.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000269688.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000269834.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000269867.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000269894.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000269900.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000269903.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000269911.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000269911.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000269919.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000269946.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000269961.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000269994.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000270001.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000270009.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000270010.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000270030.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000270066.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000270066.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000270068.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000270068.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000270069.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000270083.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000270103.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000270116.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000270117.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000270133.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000270140.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000270143.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000270154.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000270159.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000270168.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000270170.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000270189.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000270210.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000270302.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000270403.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000270419.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000270426.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000270482.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000270523.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000270557.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000270571.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000270589.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000270599.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000270640.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000270640.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000270726.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000270755.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000270828.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000270933.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000270949.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000270949.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000270988.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000271147.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000271151.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000271151.1 |
Predicted lncRNA |
Sarcoma |
|
| SL 0101-1 |
ENSG00000271199.1 |
Predicted lncRNA |
Sarcoma |
|
| SL 0101-1 |
ENSG00000271199.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000271218.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000271228.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000271320.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000271324.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000271327.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000271347.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000271366.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000271427.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000271430.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000271533.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000271551.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000271554.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000271643.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000271732.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000271734.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000271751.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000271755.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000271755.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000271755.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000271755.1 |
Predicted lncRNA |
Sarcoma |
|
| SL 0101-1 |
ENSG00000271771.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000271778.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000271780.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000271789.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000271803.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000271824.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000271826.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000271833.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000271856.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000271862.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000271874.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000271931.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000271943.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000271963.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000271963.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000271963.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000271971.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000271971.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000271978.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000271991.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000271998.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000272004.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000272004.1 |
Predicted lncRNA |
Sarcoma |
|
| SL 0101-1 |
ENSG00000272029.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000272043.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SL 0101-1 |
ENSG00000272043.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000272065.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000272068.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000272072.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000272077.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000272081.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000272088.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000272091.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000272091.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000272121.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000272142.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000272156.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000272158.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000272192.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000272192.1 |
Predicted lncRNA |
Sarcoma |
|
| SL 0101-1 |
ENSG00000272198.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000272205.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000272211.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000272217.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000272221.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000272250.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000272273.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| SL 0101-1 |
ENSG00000272282.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000272308.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000272316.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000272338.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000272354.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000272369.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000272371.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000272371.1 |
Predicted lncRNA |
Sarcoma |
|
| SL 0101-1 |
ENSG00000272375.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000272375.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000272384.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000272386.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000272403.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000272417.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000272426.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000272438.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000272465.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000272505.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000272549.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000272562.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000272574.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000272620.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000272627.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000272645.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000272646.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000272646.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000272663.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000272690.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000272692.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000272696.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000272720.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000272735.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000272754.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000272755.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000272755.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000272763.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000272764.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000272769.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000272782.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000272787.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000272787.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000272799.1 |
Predicted lncRNA |
Sarcoma |
|
| SL 0101-1 |
ENSG00000272834.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000272834.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000272849.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000272853.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000272858.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000272858.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000272872.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000272892.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000272895.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000272942.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SL 0101-1 |
ENSG00000272950.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000272966.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000272970.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000272983.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000272995.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000273001.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000273008.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000273009.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000273011.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000273017.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000273019.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000273035.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SL 0101-1 |
ENSG00000273038.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000273056.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000273058.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000273059.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000273073.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SL 0101-1 |
ENSG00000273075.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000273077.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000273116.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000273133.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000273139.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000273162.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000273188.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000273188.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000273190.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SL 0101-1 |
ENSG00000273281.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SL 0101-1 |
ENSG00000273284.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000273289.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| SL 0101-1 |
ENSG00000273302.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000273305.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000273343.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| SL 0101-1 |
ENSG00000273348.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000273350.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000273352.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000273367.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000273375.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000273384.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000273443.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SL 0101-1 |
ENSG00000273448.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SL 0101-1 |
ENSG00000273448.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| SL 0101-1 |
ENSG00000273456.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SL 0101-1 |
ENSG00000273483.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000273487.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SL 0101-1 |
ENSG00000273488.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
